What is Tonix Pharmaceuticals Holding Corp.'s Market Cap?

Tonix Pharmaceuticals Holding Corp.'s Market Cap is $225.7M, based on as-reported figures from SEC (XBRL) filings.

What is Tonix Pharmaceuticals Holding Corp.'s Enterprise Value?

Tonix Pharmaceuticals Holding Corp.'s Enterprise Value is $49.5M, based on as-reported figures from SEC (XBRL) filings.

What is Tonix Pharmaceuticals Holding Corp.'s Price / Sales?

Tonix Pharmaceuticals Holding Corp.'s Price / Sales is 7.8×, based on as-reported figures from SEC (XBRL) filings.

What is Tonix Pharmaceuticals Holding Corp.'s EV / Revenue?

Tonix Pharmaceuticals Holding Corp.'s EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.

What is Tonix Pharmaceuticals Holding Corp.'s EV / EBITDA?

Tonix Pharmaceuticals Holding Corp.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Tonix Pharmaceuticals Holding Corp.'s Revenue (TTM)?

Tonix Pharmaceuticals Holding Corp.'s Revenue (TTM) is $29.1M, based on as-reported figures from SEC (XBRL) filings.

What is Tonix Pharmaceuticals Holding Corp.'s Net Income (TTM)?

Tonix Pharmaceuticals Holding Corp.'s Net Income (TTM) is -$159.7M, based on as-reported figures from SEC (XBRL) filings.

What is Tonix Pharmaceuticals Holding Corp.'s EBITDA?

Tonix Pharmaceuticals Holding Corp.'s EBITDA is -$163.3M, based on as-reported figures from SEC (XBRL) filings.

What is Tonix Pharmaceuticals Holding Corp.'s Diluted EPS (TTM)?

Tonix Pharmaceuticals Holding Corp.'s Diluted EPS (TTM) is -9.31, based on as-reported figures from SEC (XBRL) filings.

What is Tonix Pharmaceuticals Holding Corp.'s EBITDA Margin?

Tonix Pharmaceuticals Holding Corp.'s EBITDA Margin is -561.1%, based on as-reported figures from SEC (XBRL) filings.

Tonix Pharmaceuticals Holding Corp. (TNXP) Financial Statements

Tonix Pharmaceuticals Holding Corp.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001T49NZ9

XNAS · usd

13.16▲ 0.02 (0.15%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close13.14

Day's Range12.57 – 13.48

52-Week Range9.40 – 31.55

Volume361.9K

Avg Volume466.5K

Share Statistics

Shares Outstanding

Employees142

ExchangeXNAS

Listed2009-02-13

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Tonix Pharmaceuticals Holding Corp. (TNXP)

What is Tonix Pharmaceuticals Holding Corp.'s Market Cap?: Tonix Pharmaceuticals Holding Corp.'s Market Cap is $225.7M, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s Enterprise Value?: Tonix Pharmaceuticals Holding Corp.'s Enterprise Value is $49.5M, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s Price / Sales?: Tonix Pharmaceuticals Holding Corp.'s Price / Sales is 7.8×, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s EV / Revenue?: Tonix Pharmaceuticals Holding Corp.'s EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s EV / EBITDA?: Tonix Pharmaceuticals Holding Corp.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s Revenue (TTM)?: Tonix Pharmaceuticals Holding Corp.'s Revenue (TTM) is $29.1M, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s Net Income (TTM)?: Tonix Pharmaceuticals Holding Corp.'s Net Income (TTM) is -$159.7M, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s EBITDA?: Tonix Pharmaceuticals Holding Corp.'s EBITDA is -$163.3M, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s Diluted EPS (TTM)?: Tonix Pharmaceuticals Holding Corp.'s Diluted EPS (TTM) is -9.31, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s EBITDA Margin?: Tonix Pharmaceuticals Holding Corp.'s EBITDA Margin is -561.1%, based on as-reported figures from SEC (XBRL) filings.